Fundz

Cagent secures funding to expand portfolio of angioplasty technology

PRIVATEFeb 21, 2024

Amount Raised

$30 Million

Round Type

Series C

WayneHealthcareHealth Care

Investors

Sectoral Asset ManagementBlue Ridge MedicalUS Venture Partners

Description

Cagent Vascular has closed a series C financing round, raising more than $30m, to expedite US market adoption and expand the Serration Angioplasty Technology product portfolio.

Quick answer

Cagent Vascular raised $30 Million in a Series C round, dated February 21, 2024. Investors: Sectoral Asset Management, Blue Ridge Medical and US Venture Partners. Cagent Vascular is based in Wayne, Pennsylvania, United States.

How much did Cagent Vascular raise?
Cagent Vascular raised $30 Million in a Series C round on February 21, 2024.
Who invested in Cagent Vascular?
Sectoral Asset Management, Blue Ridge Medical and US Venture Partners are named as investors in this round.
What does Cagent Vascular do?
Cagent Vascular has developed and commercialized its novel angioplasty balloon with Serration Technology to treat blocked arteries in the leg or Peripheral Artery Disease (PAD) and Chronic Limb Threatening Ischemia..
Where is Cagent Vascular based and how big is it?
Cagent Vascular is based in Wayne, Pennsylvania, United States.
Who are the decision-makers at Cagent Vascular?
Fundz holds 1 contact at Cagent Vascular, including the Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Health Care around the same time

Companies in the same sectors as Cagent Vascular that raised within 45 days of this round, from Fundz verified event records.

  • Enlaza Therapeutics raised $84M on April 5, 2024.
  • Miach Orthopaedics raised $20M (Series B) on April 2, 2024.
  • Melt Pharmaceuticals raised $24M (Series B) on April 2, 2024.
  • Vaccinex raised $1.8M (Seed) on March 29, 2024.
  • ByHeart raised $95M on March 28, 2024.
  • Miach Orthopaedics raised $20M on March 28, 2024.

Who to call at Cagent Vascular, and when

A new round usually means Cagent Vascular is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Cagent Vascular raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Cagent Vascular, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Cagent Vascular. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Cagent Vascular

Location

150 STRAFFORD AVENUE

Wayne, Pennsylvania, United States

About

Cagent Vascular has developed and commercialized its novel angioplasty balloon with Serration Technology to treat blocked arteries in the leg or Peripheral Artery Disease (PAD) and Chronic Limb Threatening Ischemia (CLTI). The Serranator PTA Serration Balloon Catheter is the first and only angioplasty balloon with serration technology.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Cagent Vascular raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsRobert G., DirectorSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Cagent Vascular's next move

See what Strategic adds

Cagent Vascular raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.